9 series
Export
<<<Page of 1 >>>Page size
Accession Title Series type(s) Organism(s) Samples GDS Supplementary Contact Release date
Remove filtersFilter Remove filterPlatform: GPL19057 Remove filterKevin C sek
GSE225526
Overexpression of FOXO1 enhances CAR T cell polyfunctionality, metabolic fitness and efficacy against solid tumors [Mouse RNAseq]
8 Kevin C sek Jan 18, 2024
GSE225527
Overexpression of FOXO1 enhances CAR T cell polyfunctionality, metabolic fitness and efficacy against solid tumors
54 Kevin C sek Jan 18, 2024
GSE230135
A2AR-eGFP reporter mouse enables elucidation of A2AR expression dynamics during anti-tumor immune responses
12 Kevin C sek Oct 03, 2023
GSE237967
A novel CRISPR/Cas9 screening platform identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and anti-tumor immunity (AT3 ATAC-Seq)
8 Kevin C sek Jul 24, 2023
GSE237968
A novel CRISPR/Cas9 screening platform identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and anti-tumor immunity (AT3 RNA-Seq)
12 Kevin C sek Jul 24, 2023
GSE237969
A novel CRISPR/Cas9 screening platform identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and anti-tumor immunity (CRISPR screen)
4 Kevin C sek Jul 24, 2023
GSE237972
A novel CRISPR/Cas9 screening platform identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and anti-tumor immunity (IRF1 ChIP-Seq)
8 Kevin C sek Jul 24, 2023
GSE237973
A novel CRISPR/Cas9 screening platform identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and anti-tumor immunity (Mouse RNA-Seq)
12 Kevin C sek Jul 24, 2023
GSE237974
A novel CRISPR/Cas9 screening platform identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and anti-tumor immunity
56 Kevin C sek Jul 22, 2023